DK171846B1 - Et kompleks, en fremgangsmåde til fremstilling af dette kompleks, en transformant vært, et rekombinant DNA-molekyle og et medikament for den specifikke stimulering af serum og sekretoriske antistoffer via mucøs tilstedeværelse af antigener - Google Patents
Et kompleks, en fremgangsmåde til fremstilling af dette kompleks, en transformant vært, et rekombinant DNA-molekyle og et medikament for den specifikke stimulering af serum og sekretoriske antistoffer via mucøs tilstedeværelse af antigener Download PDFInfo
- Publication number
- DK171846B1 DK171846B1 DK016487A DK16487A DK171846B1 DK 171846 B1 DK171846 B1 DK 171846B1 DK 016487 A DK016487 A DK 016487A DK 16487 A DK16487 A DK 16487A DK 171846 B1 DK171846 B1 DK 171846B1
- Authority
- DK
- Denmark
- Prior art keywords
- immunogen
- complex
- molecule
- carrier molecule
- carrier
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPH056685 | 1985-05-15 | ||
AUPH056685 | 1985-05-15 | ||
AUPH310485 | 1985-10-25 | ||
AUPH310485 | 1985-10-25 | ||
AU8600135 | 1986-05-14 | ||
PCT/AU1986/000135 WO1986006635A1 (fr) | 1985-05-15 | 1986-05-14 | Vaccins oraux |
Publications (3)
Publication Number | Publication Date |
---|---|
DK16487D0 DK16487D0 (da) | 1987-01-14 |
DK16487A DK16487A (da) | 1987-03-16 |
DK171846B1 true DK171846B1 (da) | 1997-06-30 |
Family
ID=25642944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK016487A DK171846B1 (da) | 1985-05-15 | 1987-01-14 | Et kompleks, en fremgangsmåde til fremstilling af dette kompleks, en transformant vært, et rekombinant DNA-molekyle og et medikament for den specifikke stimulering af serum og sekretoriske antistoffer via mucøs tilstedeværelse af antigener |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0222835B2 (fr) |
JP (1) | JP2761849B2 (fr) |
CN (1) | CN86103835A (fr) |
CA (1) | CA1340555C (fr) |
DE (1) | DE3650082T3 (fr) |
DK (1) | DK171846B1 (fr) |
ES (1) | ES8900006A1 (fr) |
FI (1) | FI870140A0 (fr) |
HK (1) | HK29896A (fr) |
IL (1) | IL78775A (fr) |
NZ (1) | NZ216162A (fr) |
WO (1) | WO1986006635A1 (fr) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8601940D0 (sv) * | 1986-04-25 | 1986-04-25 | Kabigen Ab | Preparation of fused proteins, antibodies and processes therefor |
US4822611A (en) * | 1986-12-09 | 1989-04-18 | Immunotec, Inc. | Oral hyposensitization in the treatment of allergies |
US5112749A (en) * | 1987-10-02 | 1992-05-12 | Praxis Biologics, Inc. | Vaccines for the malaria circumsporozoite protein |
US5135918A (en) * | 1988-03-21 | 1992-08-04 | Broncorp | Method for decreasing reaginic antibody levels |
JPH03502584A (ja) * | 1988-08-30 | 1991-06-13 | アプライド・リサーチ・システムス・エー・アール・エス・ホールディング・エヌ・ブイ | ホルモン分泌を変化させる組換え体融合タンパク質 |
WO1990002484A1 (fr) * | 1988-09-06 | 1990-03-22 | Washington University | Immunisation par voie orale a l'aide de plantes transgeniques |
US6043057A (en) * | 1988-09-16 | 2000-03-28 | Vitec Aktiebolag | Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides |
FR2636842B1 (fr) * | 1988-09-27 | 1994-06-10 | Liege Universite Etat | Proteine de fusion d'une sequence derivee de la sous-unite b de la toxine cholerique et d'un antigene heterologue doue de proprietes immunogenes, compositions de vaccins les contenant et acides nucleiques recombinants contenant une sequence de nucleotides codant pour ladite proteine de fusion |
AU4754490A (en) * | 1988-12-07 | 1990-06-26 | University Of Leicester | Heat-labile toxin b subunit fusion proteins |
WO1990007525A1 (fr) * | 1989-01-06 | 1990-07-12 | The Regents Of The University Of California | Cytotoxine de la keratoconjonctivite et ses procedes d'utilisation et de production |
US6413523B1 (en) * | 1989-06-02 | 2002-07-02 | The United States Of America As Represented By The Secretary Of The Navy | Pharmaceutical composition of escherichia coli heat-labile enterotoxin adjuvant and methods of use |
DE69005572T2 (de) * | 1989-09-08 | 1994-04-07 | Takeda Chemical Industries Ltd | Fusionsproteine und Herstellung davon. |
US5032405A (en) * | 1989-09-27 | 1991-07-16 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
US5378815A (en) * | 1989-10-20 | 1995-01-03 | National Research Council Canada | Process for indirect targeted immunocytolysis |
CA2050425A1 (fr) * | 1990-09-03 | 1992-03-04 | Yoshiaki Uda | Composition pharmaceutique et son utilisation avec du mucus |
US5241053A (en) * | 1990-09-05 | 1993-08-31 | Takeda Chemical Industries, Ltd. | Fused proteins comprising glycoprotein gD of HSV-1 and LTB |
EP0565590B1 (fr) * | 1990-12-21 | 1999-03-03 | Antex Biologics, Inc. | VACCIN CONJUGUE ADHESINE-OLIGOSACCHARIDE CONTRE $i(HAEMOPHILUS INFLUENZAE) |
US5843463A (en) * | 1990-12-21 | 1998-12-01 | Antexbiologics, Inc. | Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae |
PL296623A1 (en) * | 1991-03-01 | 1993-09-20 | Rhone Merieux | Method of improving organoleptic properties of male slaughter animal meat |
WO1992017167A1 (fr) * | 1991-04-02 | 1992-10-15 | Biotech Australia Pty. Ltd. | Systemes de liberation orale de microparticules |
GB9112553D0 (en) * | 1991-06-11 | 1991-07-31 | Wellcome Found | Fusion proteins |
ZA934199B (en) * | 1992-06-18 | 1994-01-10 | Akzo Nv | Carrier system against gnrh |
DK0603992T4 (da) * | 1992-12-22 | 2001-03-05 | Univ Cincinnati | Oral indgivelse af immunologisk aktive biomolekyler og andre terapeutiske proteiner |
US5681571A (en) * | 1993-10-08 | 1997-10-28 | Duotol Ab | Immunological tolerance-inducing agent |
US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
US6030613A (en) * | 1995-01-17 | 2000-02-29 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
US6086875A (en) * | 1995-01-17 | 2000-07-11 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of immunogens |
US6485726B1 (en) | 1995-01-17 | 2002-11-26 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
DK1323346T3 (da) * | 1995-01-17 | 2006-10-30 | Brigham & Womens Hospital | Receptorspecifik transport af immunogener gennem epitelet |
EP0840796A2 (fr) * | 1995-07-26 | 1998-05-13 | Maxim Pharmaceuticals | Apport de polynucleotides dans les muqueuses |
DE19534579C2 (de) * | 1995-09-18 | 2000-06-08 | Max Planck Gesellschaft | Nucleinsäure-Moleküle codierend Proteine, die die Adhäsion von Neisseria-Zellen an humane Zellen vermitteln |
JP2000509270A (ja) | 1996-04-19 | 2000-07-25 | ヘンリー エム.ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン | ヒスチジンタグ付きインチミン、ならびに免疫応答を刺激し、標的能力を有する抗原担体としてインチミンを使用する方法 |
JP2000510332A (ja) | 1996-04-19 | 2000-08-15 | ヘンリー エム.ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン | インチミンを単独で、または1以上の他の抗原との融合タンパク質として発現する宿主生物の投与による、免疫応答を刺激する方法 |
US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
US7914791B1 (en) | 1998-05-08 | 2011-03-29 | Trident Pharmaceuticals, Inc. | Vaccine |
US7087236B1 (en) | 1998-09-01 | 2006-08-08 | Merrion Research I Limited | Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
ES2233284T3 (es) | 1999-02-17 | 2005-06-16 | Pfizer Products Inc. | Proteinas de fusion que comprenden portadores que pueden inducir una bdoble respuesta inmune. |
FR2791895B1 (fr) * | 1999-03-23 | 2001-06-15 | Pasteur Merieux Serums Vacc | Utilisation de trehalose pour stabiliser un vaccin liquide |
JP2003512441A (ja) * | 1999-10-22 | 2003-04-02 | アメリカ合衆国 | 極性上皮細胞層を横断するタンパク質の送達 |
US6863896B1 (en) | 1999-10-26 | 2005-03-08 | Chiron Corporation | Plant lectins as mucosal adjuvants |
WO2001034193A1 (fr) * | 1999-10-26 | 2001-05-17 | Chiron Corporation | Lectines vegetales en tant qu'adjuvants des muqueuses |
JP2001335510A (ja) * | 2000-05-23 | 2001-12-04 | Masanori Baba | エイズワクチン |
BRPI0408167B1 (pt) * | 2003-03-07 | 2014-10-21 | Wyeth Corp | Conjugados de polissacarídeo-proteína veículo adesina da superfície estafilocócica para imunização contra infecções nosocomiais |
PL1787126T3 (pl) * | 2004-07-20 | 2010-03-31 | Symphogen As | Sposób charakteryzowania poliklonalnej linii komórkowej |
AU2005296064A1 (en) | 2004-10-04 | 2006-04-27 | Trinity Biosystems, Inc. | Methods and compositions for needleless delivery of macromolecules |
CA2623531C (fr) * | 2005-10-07 | 2013-12-10 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Vaccin de metalloproteinase 11 matricielle |
CA2631952A1 (fr) | 2005-12-05 | 2007-06-14 | Trinity Biosystems, Inc. | Procedes et compositions servant a l'apport, sans aiguille, d'anticorps |
AU2007224034B2 (en) | 2006-03-07 | 2012-03-29 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
WO2009128949A2 (fr) | 2008-04-18 | 2009-10-22 | Vaxinnate Corporation | Compositions de proteines du virus de la dengue et methodes d’utilisation associees |
EP3461496B1 (fr) | 2009-06-22 | 2023-08-23 | Wyeth LLC | Compositions et procédés d'élaboration de compositions immunogènes conjuguées à polysaccharides capsulaires de sérotypes 5 et 8 de staphylococcus aureus |
MX2012000044A (es) | 2009-06-22 | 2012-01-30 | Wyeth Llc | Composiciones inmunogenicas de antigenos de staphylococcus aureus. |
CN101921726B (zh) * | 2010-07-27 | 2012-08-22 | 浙江大学 | 一种口服免疫阻断鸡抑制素作用的转化子及其应用 |
CN102178699B (zh) * | 2011-04-20 | 2013-03-20 | 威海康博尔生物药业有限公司 | 一种用于增强人体免疫力、促进生长发育的制剂 |
US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
US10617650B2 (en) | 2015-10-16 | 2020-04-14 | Merck Sharp & Dohme Corp. | Process for preparing formulations for gastrointestinal-targeted therapies |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2547224A1 (de) * | 1974-11-01 | 1976-05-13 | Sandoz Ag | Organische verbindungen, ihre verwendung und herstellung |
FR2306684A1 (fr) * | 1975-04-11 | 1976-11-05 | Crinex Lab | Nouvelle composition a action immunostimulante |
GB1553664A (en) * | 1975-06-12 | 1979-09-26 | Unilever Ltd | Antigenic compositions |
ZA802992B (en) * | 1979-06-01 | 1981-10-28 | Univ California | Human pre-growth hormone |
JPS5639022A (en) * | 1979-09-05 | 1981-04-14 | Hayashibara Biochem Lab Inc | Preparation of vaccine |
DE3153267A1 (fr) * | 1980-03-17 | 1985-08-14 | ||
EP0049945A3 (fr) * | 1980-09-15 | 1982-12-01 | Bactex Incorporated | Méthode pour la détermination de la hiérarchie des organismes piliés et vaccin préparé à partir de ces organismes |
GB2094314A (en) * | 1981-02-05 | 1982-09-15 | Wellcome Found | Recombinant DNA |
NZ199866A (en) * | 1981-03-09 | 1984-11-09 | Cetus Corp | Vaccine for prevention of gastroenteric disease:non-pathogenic strain genetically engineered to comprise genes for adhesin and/or toxoids |
US4593002A (en) * | 1982-01-11 | 1986-06-03 | Salk Institute Biotechnology/Industrial Associates, Inc. | Viruses with recombinant surface proteins |
CA1203164A (fr) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Conjugats d'anticorps |
ES8407097A1 (es) * | 1982-05-12 | 1984-08-16 | Harvard College | Un procedimiento para obtener una proteina hibrida. |
US4496538A (en) * | 1982-07-06 | 1985-01-29 | Connaught Laboratories, Inc. | Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine |
EP0116201B1 (fr) * | 1983-01-12 | 1992-04-22 | Chiron Corporation | Expression sécrétoire en eukaryotes |
DK219084D0 (da) * | 1984-05-02 | 1984-05-02 | Frederik Carl Peter Lindberg | Antigen |
AU582358B2 (en) * | 1984-04-06 | 1989-03-23 | Scripps Clinic And Research Foundation | A peptide vaccine or diagnostic, and a polypeptide useful therefor |
US4808700A (en) * | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
DE3586386T2 (de) * | 1984-10-05 | 1993-01-14 | Genentech Inc | Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung. |
NZ213759A (en) * | 1984-10-19 | 1989-01-27 | Genentech Inc | Lhrh-ctp protein conjugates influencing prolactin fsh and lh release |
US4556555A (en) * | 1985-01-25 | 1985-12-03 | North Carolina State University | Process for the immunological neutering of animals |
-
1986
- 1986-05-13 IL IL78775A patent/IL78775A/xx not_active IP Right Cessation
- 1986-05-14 EP EP86903134A patent/EP0222835B2/fr not_active Expired - Lifetime
- 1986-05-14 WO PCT/AU1986/000135 patent/WO1986006635A1/fr active IP Right Grant
- 1986-05-14 DE DE3650082T patent/DE3650082T3/de not_active Expired - Fee Related
- 1986-05-14 NZ NZ216162A patent/NZ216162A/en unknown
- 1986-05-14 ES ES554969A patent/ES8900006A1/es not_active Expired
- 1986-05-15 CN CN198686103835A patent/CN86103835A/zh active Pending
- 1986-05-15 CA CA000509225A patent/CA1340555C/fr not_active Expired - Fee Related
-
1987
- 1987-01-14 FI FI870140A patent/FI870140A0/fi not_active Application Discontinuation
- 1987-01-14 DK DK016487A patent/DK171846B1/da not_active IP Right Cessation
-
1995
- 1995-01-05 JP JP7015505A patent/JP2761849B2/ja not_active Expired - Lifetime
-
1996
- 1996-02-15 HK HK29896A patent/HK29896A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU594059B2 (en) | 1990-03-01 |
AU5861286A (en) | 1986-12-04 |
IL78775A (en) | 1992-06-21 |
IL78775A0 (en) | 1986-08-31 |
JPH07213290A (ja) | 1995-08-15 |
JP2761849B2 (ja) | 1998-06-04 |
FI870140A (fi) | 1987-01-14 |
ES8900006A1 (es) | 1988-10-16 |
FI870140A0 (fi) | 1987-01-14 |
DE3650082T2 (de) | 1995-05-04 |
DE3650082D1 (de) | 1994-11-03 |
HK29896A (en) | 1996-02-23 |
EP0222835B2 (fr) | 2000-04-19 |
CA1340555C (fr) | 1999-05-25 |
NZ216162A (en) | 1989-04-26 |
DK16487A (da) | 1987-03-16 |
DK16487D0 (da) | 1987-01-14 |
ES554969A0 (es) | 1988-10-16 |
CN86103835A (zh) | 1987-04-08 |
DE3650082T3 (de) | 2000-12-21 |
WO1986006635A1 (fr) | 1986-11-20 |
EP0222835A4 (fr) | 1988-02-01 |
EP0222835A1 (fr) | 1987-05-27 |
EP0222835B1 (fr) | 1994-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK171846B1 (da) | Et kompleks, en fremgangsmåde til fremstilling af dette kompleks, en transformant vært, et rekombinant DNA-molekyle og et medikament for den specifikke stimulering af serum og sekretoriske antistoffer via mucøs tilstedeværelse af antigener | |
De Aizpurua et al. | Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. | |
US6103243A (en) | Oral vaccines | |
Ellis | Vaccines: New approaches to immunological problems | |
US7960535B2 (en) | Recombinant lipidated PsaA protein, methods of preparation and use | |
US20050244425A1 (en) | Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability | |
Oaks et al. | Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine | |
JP2012139221A (ja) | 肺炎球菌感染を治療または予防するための組成物および方法 | |
KR20010021953A (ko) | B군 수막염균 포린 및 에이치.인플루엔자 다당류를포함하는 면역원성 접합체 | |
US9011871B2 (en) | Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease | |
LEVINE et al. | Pediatric diarrhea: the challenge of prevention | |
EP0682950B1 (fr) | Administration mucosale d'antigènes de pneumococcus | |
CZ281556B6 (cs) | Způsob výroby kompozitní vakcíny proti střevní infekci způsobené enterotexigenickými bakteriemi E. coli | |
JPH05503420A (ja) | キメラタンパク質 | |
EP0365646A1 (fr) | Peptides synthetiques provenant de proteines streptococciques m et vaccins prepares a partir de ces peptides. | |
Lasaro et al. | Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli | |
AU594059C (en) | Oral vaccines | |
Jacob et al. | Identification of a 33 kDa antigen associated with an adhesive and colonizing strain of Vibrio cholerae El Tor and its role in protection | |
Klipstein et al. | Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin | |
NO870148L (no) | Orale vaksiner. | |
JP2660511B2 (ja) | 経口ワクチン | |
Svennerholm et al. | Immunity to enterotoxin-producing bacteria | |
Freytag | Effect of gene location on in vitro and in vivo stability, immunogenicity and expression of foreign antigens in bacterial vaccine fectors | |
Dickinson | Construction and characterization of a non-toxic mutant of the Escherichia coli heat-labile enterotoxin effective as an oral adjuvant | |
Guinée et al. | Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment | ||
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |